Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15 — Stella

Home/Pneumococcal Disease/Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

View on ClinicalTrials.gov

Recruiting

Back to Pneumococcal Disease trials

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

United Kingdom

Liverpool Vaccine Group, Liverpool, North West

Oxford Vaccine Group, Oxford, Oxfordshire

Key details

Phase

Post-approval study

Sponsor

University of Oxford

Collaborators

Liverpool School of Tropical Medicine, United Kingdom, Oxford University Hospitals NHS Trust

Enrollment target

~106 participants

Started

February 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 50 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.